Figure 1
The flowchart illustrates the stages of the PRISMA-Scr process for scoping reviews. It begins with the identification phase, where studies from databases or registers, specifically PubMed, total 256. One reference is removed due to duplicates identified by Covidence. This leaves 255 studies to be screened. Out of these, 175 studies are excluded, resulting in 80 studies sought for retrieval. All 80 studies are retrieved, and none are excluded at this stage. These 80 studies are then assessed for eligibility, with 45 studies excluded for various reasons such as wrong setting, wrong outcomes, wrong intervention, wrong study design, not addressing equity, wrong population group, or being a review rather than original research. Finally, 35 studies are included in the review.Preferred Reporting Items for Systematic Reviews and Meta Analysis extension for scoping reviews (PRISMA-Scr)